RVNC - Revance Therapeutics Inc. (RVNC) CEO Mark Foley on Q3 2021 Results - Earnings Call Transcript

Revance Therapeutics, Inc. (RVNC) Q3 2021 Earnings Conference Call November 9, 2021 04:30 PM ET Company Participants Jessica Serra - IR Mark Foley - CEO Dustin Sjuts - President Toby Schilke - CFO Roman Rubio - SVP, Clinical Development Conference Call Participants Ken Cacciatore - Cowen and Company David Amsellem - Piper Sandler Seamus Fernandez - Guggenheim Nick Rubino - Stifel Vamil Divan - Mizuho Tim Lugo - William Blair Presentation Operator Welcome to Revance Therapeutics Third Quarter 2021 Financial Results and Corporate Update Conference Call. [Operator Instructions] As a reminder, this call is being recorded today, 9th of November 2021. I would now like to turn the conference call over to Jessica Serra, Head of Investor Relations and ESG of Revance. Please go ahead. Jessica Serra Thank you, Laurie. Joining us on the call today from Revance, are Chief Executive Officer, Mark Foley; President, Dustin Sjuts; Chief Financial Officer,

For further details see:

Revance Therapeutics, Inc. (RVNC) CEO Mark Foley on Q3 2021 Results - Earnings Call Transcript